Marie Kaufmann
Family · Arlington, VANPI 1447805510
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 154 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 27 manufacturers, the largest accounting for just 15.4% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $2,142, more than ten times the $66 reported in 2022. Among family clinicians in VA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 154 payments — averaging $23.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$552
- AstraZeneca$403
- Pfizer$365
- Viiv Healthcare Company$296
- AbbVie$292
- Gilead$219
- plus $1K from 21 others
What the payments were for
- Food & beverage$3,578100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 27 | $552 |
| AstraZeneca | 18 | $403 |
| Pfizer | 16 | $365 |
| Viiv Healthcare Company | 8 | $296 |
| AbbVie | 15 | $292 |
| Gilead | 9 | $219 |
| Lilly USA, LLC | 9 | $197 |
| Novartis | 7 | $163 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 5 | $140 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 7 | $137 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $131 |
| Exact Sciences | 4 | $110 |
| Amgen | 5 | $109 |
| GSK | 4 | $90 |
| Phadia US Inc. | 1 | $66 |
| Merck | 2 | $44 |
| Abbott | 2 | $43 |
| Inspire Medical Systems, Inc. | 1 | $33 |
| Otsuka America Pharmaceutical, Inc. | 1 | $27 |
| Bayer | 1 | $26 |
| Baxter Healthcare | 1 | $26 |
| Cepheid | 1 | $26 |
| Teva Pharmaceuticals USA, Inc. | 1 | $21 |
| E.r. Squibb & Sons, L.L.C. | 1 | $17 |
| Esperion Therapeutics, Inc. | 1 | $17 |
| Astellas Pharma Global Development | 1 | $14 |
| Watermark Medical, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- APRETUDE$120
How this compares
$3,578 in reported general payments places this provider in the 90th percentile of 4,332 family providers in Virginia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atorvastatin Calcium | 70 | $775 |
| Rosuvastatin Calcium | 16 | $359 |
| Levothyroxine Sodium | 20 | $281 |
| Alendronate Sodium | 12 | $222 |
| Metformin Hcl ErMetformin Hcl | 15 | $191 |
| Amlodipine Besylate | 23 | $185 |
| Losartan Potassium | 21 | $123 |
| Metformin Hcl | 19 | $85 |
| Lisinopril | 19 | $76 |
| Cyclobenzaprine Hcl | 11 | $75 |
| Pantoprazole Sodium | 13 | $71 |
| Omeprazole | 12 | $56 |
Paid to pharmacies, not to this prescriber.
Other family in Arlington
- Andrea CottonVirginia Beach$696K
- Susan MooreWytheville$438K
- Ellen WermterCharlottesville$251K
- Dana StallingsFranklin$225K
- Jocelyn BrackettHerndon$199K
- Hochong Smith GillesRichmond$131K
- Sean OlaughlinMidlothian$110K
- Adam MedlinHampton$67K
- Casey SharpDanville$63K
- Norman JacobowitzManassas$55K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.